Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 28, 2025 | (Q2)Jun 29, 2025 | (Q1)Mar 30, 2025 | (FY)Dec 29, 2024 | (Q4)Dec 29, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23.69%879.86M | 1.99%868.17M | 16.42%841.42M | 15.96%3.12B | 5.06%836.99M | 0.14%711.34M | 28.92%851.23M | 37.63%722.75M | 2.69B | 796.71M |
| Operating revenue | 23.69%879.86M | 1.99%868.17M | 16.42%841.42M | 15.96%3.12B | 5.06%836.99M | 0.14%711.34M | 28.92%851.23M | 37.63%722.75M | --2.69B | --796.71M |
| Cost of revenue | 59.18%994.18M | 0.28%751.93M | 14.33%747.46M | 12.18%2.77B | 4.93%744.73M | -5.46%624.55M | 22.44%749.79M | 33.73%653.8M | 2.47B | 709.77M |
| Gross profit | -231.72%-114.33M | 14.59%116.24M | 36.27%93.96M | 58.29%349.44M | 6.12%92.26M | 74.65%86.79M | 111.81%101.44M | 90.27%68.95M | 220.77M | 86.94M |
| Operating expense | -12.46%53.23M | 28.67%82.68M | 10.88%63.23M | -2.51%239.12M | -9.42%57.02M | -2.95%60.81M | 3.81%64.26M | -1.26%57.03M | 245.27M | 62.95M |
| Selling and administrative expenses | -12.46%53.23M | 28.67%82.68M | 10.88%63.23M | -2.51%239.12M | -9.42%57.02M | -2.95%60.81M | 3.81%64.26M | -1.26%57.03M | --245.27M | --62.95M |
| Operating profit | -744.77%-167.56M | -9.74%33.56M | 157.79%30.73M | 550.31%110.33M | 46.89%35.24M | 300.47%25.99M | 365.35%37.18M | 155.39%11.92M | -24.5M | 23.99M |
| Net non-operating interest income (expenses) | 9.90%-32.42M | -7.86%-37.5M | 1.71%-37.96M | -7.83%-146.63M | 1.64%-37.26M | -1.23%-35.98M | -3.95%-34.77M | -31.95%-38.62M | -135.98M | -37.88M |
| Non-operating interest expense | -9.90%32.42M | 7.86%37.5M | -1.71%37.96M | 7.83%146.63M | -1.64%37.26M | 1.23%35.98M | 3.95%34.77M | 31.95%38.62M | --135.98M | --37.88M |
| Other net income (expenses) | 263.20%7.58M | -6,281.40%-145.88M | -89.08%1.23M | 447.35%29.84M | 3,379.87%20.86M | -215.29%-4.64M | 125.52%2.36M | 511.74%11.26M | -8.59M | -636K |
| Gain on sale of security | 152.21%5.24M | -546.04%-9.36M | -64.98%3.38M | 232.35%22.96M | 10,082.16%21.26M | -64.51%-10.05M | 125.34%2.1M | 450.51%9.65M | ---17.35M | ---213K |
| Special income (charges) | 35,236.36%3.87M | -52,265.97%-150.81M | 116.11%150K | -133.30%-2.7M | 4.16%-1.47M | -100.10%-11K | 70.28%-288K | -5,576.47%-931K | --8.12M | ---1.54M |
| -Less:Impairment of capital assets | ---3.83M | --96.81M | --0 | --2.28M | --1.25M | --0 | --0 | --1.03M | --0 | --0 |
| -Less:Other special charges | ---- | 22,981.20%54.01M | ---- | 102.63%234K | --0 | ---- | --234K | ---- | ---8.91M | --1.6M |
| -Gain on sale of property,plant,equipment | 427.27%36K | 118.52%10K | 54.64%150K | 75.67%-192K | -461.29%-224K | -110.89%-11K | 94.43%-54K | 470.59%97K | ---789K | --62K |
| Other non-operating income (expenses) | -128.27%-1.53M | 2,498.36%14.29M | -190.26%-2.3M | 1,396.88%9.58M | -3.86%1.07M | 1,239.37%5.41M | --550K | --2.55M | --640K | --1.12M |
| Income before tax | -1,214.78%-192.39M | -3,245.03%-149.83M | 61.11%-6.01M | 96.18%-6.46M | 229.79%18.85M | 67.10%-14.63M | 108.40%4.76M | 71.15%-15.44M | -169.07M | -14.52M |
| Income tax | -14,409.17%-51.51M | 393.69%10.95M | 107.96%480K | 90.37%-3.17M | 102.33%284K | 107.92%360K | 125.76%2.22M | 20.27%-6.03M | -32.91M | -12.19M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -839.63%-140.88M | -6,412.29%-160.77M | 31.10%-6.49M | 97.58%-3.3M | 897.04%18.56M | 62.45%-14.99M | 105.30%2.55M | 79.52%-9.41M | -136.16M | -2.33M |
| Net income continuous operations | -839.63%-140.88M | -6,412.29%-160.77M | 31.10%-6.49M | 97.58%-3.3M | 897.04%18.56M | 62.45%-14.99M | 105.30%2.55M | 79.52%-9.41M | ---136.16M | ---2.33M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -839.63%-140.88M | -6,412.29%-160.77M | 31.10%-6.49M | 97.58%-3.3M | 897.04%18.56M | 62.45%-14.99M | 105.30%2.55M | 79.52%-9.41M | -136.16M | -2.33M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -839.63%-140.88M | -6,412.29%-160.77M | 31.10%-6.49M | 97.58%-3.3M | 897.04%18.56M | 62.45%-14.99M | 105.30%2.55M | 79.52%-9.41M | -136.16M | -2.33M |
| Diluted earnings per share | -807.69%-1.18 | -6,850.00%-1.35 | 37.50%-0.05 | 98.13%-0.0277 | 16.11%0.16 | 69.05%-0.13 | 103.23%0.02 | 86.57%-0.08 | -1.4822 | 0.1378 |
| Basic earnings per share | -807.69%-1.18 | -6,850.00%-1.35 | 37.50%-0.05 | 98.13%-0.0277 | 16.11%0.16 | 69.05%-0.13 | 103.23%0.02 | 86.57%-0.08 | -1.4822 | 0.1378 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.